Physician profile
Lance Gutierrez
NPI 1649935677
$1,328.13
in general payments reported to CMS, 2019-2025
11 companies · $17.56 in 2025
The $17.56 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.62 · 2022: $475 · 2023: $822 · 2025: $17.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $434.62 | 2021-2023 | Ocaliva |
| Boston Scientific Corporation | $392.06 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Shockwave Medical, INC | $180.09 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $175.66 | 2022-2023 | Xifaxan |
| Gilead Sciences, INC. | $55.33 | 2023 | |
| Abiomed | $17.56 | 2025 | |
| Vbi Vaccine (Delaware) INC. | $16.22 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $16.09 | 2023 | Bylvay |
| Laborie Medical Technologies Corp. | $13.73 | 2022 | |
| Travere Therapeutics, INC. | $13.59 | 2022 | |
| Albireo Pharma, INC. | $13.18 | 2023 | Bylvay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.